MindWalk Holdings (HYFT) Non-Current Assets (2020 - 2026)
MindWalk Holdings (HYFT) reported Non-Current Assets of $3.0 million for Q1 2026, down 82.79% year-over-year from $17.5 million in Q1 2025, and down 4.44% quarter-over-quarter from $3.1 million in Q4 2025.
MindWalk Holdings (HYFT) Non-Current Assets (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Non-Current Assets data on file, last reported at $3.0 million in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $3.0 million, down 82.79% year-over-year; the trailing twelve-month figure through Jan 2026 was $26.9 million (down 80.02% YoY), and the FY2025 annual result was $18.4 million, down 48.45% from the prior year.
- Non-Current Assets retreated to $3.0 million in Q1 2026 per HYFT's latest filing, from $3.1 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $47.1 million in Q1 2023 and troughed at $3.0 million in Q1 2026.
- A 5-year average of $30.8 million and a median of $35.8 million in 2024 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2023 and 2025: Non-Current Assets jumped 275.42% in 2023, then plunged 90.95% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $45.2 million in 2022, then fell by 1.83% to $44.4 million in 2023, then slipped by 21.72% to $34.8 million in 2024, then sank by 90.95% to $3.1 million in 2025, then slipped by 4.44% to $3.0 million in 2026.
- Business Quant data shows HYFT's Non-Current Assets at $3.0 million in Q1 2026, $3.1 million in Q4 2025, and $3.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 62,953.78 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 39.71 Mn |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | 3.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 3.01 Mn |
| Oct 31, 2025 | 3.15 Mn |
| Jul 31, 2025 | 3.27 Mn |
| Apr 30, 2025 | 18.05 Mn |
| Jan 31, 2025 | 17.46 Mn |
| Oct 31, 2024 | 34.76 Mn |
| Jul 31, 2024 | 35.26 Mn |
| Apr 30, 2024 | 35.77 Mn |
| Jan 31, 2024 | 47.07 Mn |
| Oct 31, 2023 | 44.40 Mn |
| Jul 31, 2023 | 45.60 Mn |
| Apr 30, 2023 | 45.10 Mn |
| Jan 31, 2023 | 47.13 Mn |
| Oct 31, 2022 | 45.23 Mn |
| Jul 31, 2022 | 41.10 Mn |
| Apr 30, 2022 | 44.35 Mn |
| Jan 31, 2022 | 12.55 Mn |
| Oct 31, 2021 | 13.03 Mn |
| Jul 31, 2021 | 14.34 Mn |
| Apr 30, 2021 | 14.38 Mn |